Comparative Pharmacology
Head-to-head clinical analysis: NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM LACTATE 1 6 MOLAR IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM LACTATE 1 6 MOLAR IN PLASTIC CONTAINER.
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Normosol-R and Dextrose 5% is a balanced electrolyte solution with dextrose. The dextrose provides caloric support and prevents ketosis. The electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain osmotic balance and acid-base homeostasis. Acetate and gluconate serve as bicarbonate precursors to correct acidosis.
Sodium lactate is a source of bicarbonate precursor. It is metabolized to bicarbonate in the liver, which buffers metabolic acidosis, restoring acid-base balance.
Intravenous infusion; dose depends on fluid and electrolyte needs. Typical adult dose: 500-1000 mL over 1-4 hours, may repeat based on clinical status.
Intravenous infusion: The typical adult dose is 300-500 mL of 1/6 Molar sodium lactate solution (approximately 167 mEq/L each of sodium and lactate, 1 L contains 167 mEq of sodium and lactate) administered as a continuous intravenous infusion at a rate of 0.5-2.5 mL/kg/hour, adjusted based on the severity of acidosis and clinical response. Maximum infusion rate: 2.5 mL/kg/hour.
None Documented
None Documented
Dextrose: <15 minutes (rapid cellular uptake and metabolism). Electrolytes distribute and are excreted with kinetics dependent on renal function; no plasma half-life defined.
30–60 minutes for lactate conversion; bicarbonate component determined by CO2 excretion.
Renal elimination of water and electrolytes; dextrose is metabolized to CO2 and water, with <5% excreted unchanged. Biliary/fecal excretion negligible.
Primarily renal as bicarbonate and lactate; <5% unchanged.
Category C
Category C
Intravenous Fluid/Electrolyte Solution
Electrolyte Solution